356 related articles for article (PubMed ID: 35028850)
41. Biochemical properties of indoleamine 2,3-dioxygenase: from structure to optimized design of inhibitors.
Lancellotti S; Novarese L; De Cristofaro R
Curr Med Chem; 2011; 18(15):2205-14. PubMed ID: 21517759
[TBL] [Abstract][Full Text] [Related]
42. Influence of core body temperature on Tryptophan metabolism, kynurenines, and estimated IDO activity in critically ill patients receiving target temperature management following cardiac arrest.
Schefold JC; Fritschi N; Fusch G; Bahonjic A; Doehner W; von Haehling S; Pschowski R; Storm C; Schroeder T
Resuscitation; 2016 Oct; 107():107-14. PubMed ID: 27565863
[TBL] [Abstract][Full Text] [Related]
43. Role of indoleamine 2,3-dioxygenase in testicular immune-privilege.
Gualdoni GS; Jacobo PV; Sobarzo CM; Pérez CV; Matzkin ME; Höcht C; Frungieri MB; Hill M; Anegon I; Lustig L; Guazzone VA
Sci Rep; 2019 Nov; 9(1):15919. PubMed ID: 31685866
[TBL] [Abstract][Full Text] [Related]
44. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
[TBL] [Abstract][Full Text] [Related]
45. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease.
Macchiarulo A; Camaioni E; Nuti R; Pellicciari R
Amino Acids; 2009 Jul; 37(2):219-29. PubMed ID: 18612775
[TBL] [Abstract][Full Text] [Related]
46. Molecules in focus: indoleamine 2,3-dioxygenase.
King NJ; Thomas SR
Int J Biochem Cell Biol; 2007; 39(12):2167-72. PubMed ID: 17320464
[TBL] [Abstract][Full Text] [Related]
47. Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
Di Pucchio T; Danese S; De Cristofaro R; Rutella S
Expert Opin Ther Pat; 2010 Feb; 20(2):229-50. PubMed ID: 20100004
[TBL] [Abstract][Full Text] [Related]
48. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM
Haematologica; 2010 Dec; 95(12):2022-30. PubMed ID: 20801903
[TBL] [Abstract][Full Text] [Related]
49. Dimethyl- and monomethylfumarate regulate indoleamine 2,3-dioxygenase (IDO) activity in human immune cells.
Eminel S; Jin N; Rostami M; Dibbert S; Mrowietz U; Suhrkamp I
Exp Dermatol; 2017 Aug; 26(8):685-690. PubMed ID: 27376248
[TBL] [Abstract][Full Text] [Related]
50. Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer.
Lanser L; Kink P; Egger EM; Willenbacher W; Fuchs D; Weiss G; Kurz K
Front Immunol; 2020; 11():249. PubMed ID: 32153576
[TBL] [Abstract][Full Text] [Related]
51. No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients.
Bigenzahn S; Juergens B; Mahr B; Pratschke J; Koenigsrainer A; Becker T; Fuchs D; Brandacher G; Kainz A; Muehlbacher F; Wekerle T
Clin Exp Immunol; 2018 May; 192(2):233-241. PubMed ID: 29271486
[TBL] [Abstract][Full Text] [Related]
52. The tryptophan metabolism, kynurenine pathway and oxidative stress - implications for glioma pathobiology.
Obara-Michlewska M
Neurochem Int; 2022 Sep; 158():105363. PubMed ID: 35667490
[TBL] [Abstract][Full Text] [Related]
53. The Role of the Kynurenine Signaling Pathway in Different Chronic Pain Conditions and Potential Use of Therapeutic Agents.
Jovanovic F; Candido KD; Knezevic NN
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842609
[TBL] [Abstract][Full Text] [Related]
54. Suppression of experimental autoimmune glomerulonephritis by tryptophan.
Hou W; Huang G; Cao X; Zhang Y; Zhang J; Li Y
J Nephrol; 2014 Feb; 27(1):19-28. PubMed ID: 24519862
[TBL] [Abstract][Full Text] [Related]
55. Identification and characterization of tryptophan-kynurenine pathway-related genes involving lamprey (Lampetra japonica) innate immunity.
Luan Y; Wang Y; Zhang W; Duan X; Su P; Li Q; Pang Y; Gou M
Fish Shellfish Immunol; 2023 Sep; 140():108967. PubMed ID: 37488041
[TBL] [Abstract][Full Text] [Related]
56. Clinical Relevance of Kynurenine Pathway in HIV/AIDS: An Immune Checkpoint at the Crossroads of Metabolism and Inflammation.
Routy JP; Mehraj V; Vyboh K; Cao W; Kema I; Jenabian MA
AIDS Rev; 2015; 17(2):96-106. PubMed ID: 26035167
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice.
Szántó S; Koreny T; Mikecz K; Glant TT; Szekanecz Z; Varga J
Arthritis Res Ther; 2007; 9(3):R50. PubMed ID: 17511858
[TBL] [Abstract][Full Text] [Related]
58. Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice.
Larkin PB; Sathyasaikumar KV; Notarangelo FM; Funakoshi H; Nakamura T; Schwarcz R; Muchowski PJ
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2345-2354. PubMed ID: 27392942
[TBL] [Abstract][Full Text] [Related]
59. Role of indoleamine 2,3-dioxygenase in acute myeloid leukemia.
Sobash PT; Kolhe R; Karim NA; Guddati AK; Jillella A; Kota V
Future Oncol; 2020 Dec; 16(36):3085-3094. PubMed ID: 32976029
[TBL] [Abstract][Full Text] [Related]
60. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.
Favre D; Mold J; Hunt PW; Kanwar B; Loke P; Seu L; Barbour JD; Lowe MM; Jayawardene A; Aweeka F; Huang Y; Douek DC; Brenchley JM; Martin JN; Hecht FM; Deeks SG; McCune JM
Sci Transl Med; 2010 May; 2(32):32ra36. PubMed ID: 20484731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
